speb/financial-data huggingface dataset:
Financial ratios for BHR — quarterly report dated 2025-06-30
Total revenue: 179077000
Gross profit: 46147000
Operating income: 17894000
Net income: -5467000
Capital expenditures: 0
Operating cash flow: 23049000
Depreciation & amortization: 23467000
Net tangible assets: 222192000
Owner earnings: 18000000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.36
P/E ratio: 29.30450017718315
Shares outstanding: 68679318
Book value: 239801000
P/B ratio: 0.6759070666093969
Market cap (USD): 162083190.48
Debt to equity: 5.132914374835801
Current ratio: 1.4571889365984108
Quick ratio: 1.4245404608142476
Interest coverage ratio: 0.705571546863294
COGS to revenue (%): 74.2306382170798
SG&A to revenue (%): 2.7323441871373766
Free cash flow (dilution-adjusted): 17587000
Buyback yield (%): 9.026229035024608
Retained earnings: -502437000
Inventory turnover: 28.06206459784674
Receivables turnover: 2.734208718222765
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9323895151772525
FCF margin (%): 9.820915025380144
Revenue growth (%): -17.024835511074045
Rule of 40 score: -7.203920485693901
Financial ratios for BHR — quarterly report dated 2025-09-30
Total revenue: 143556000
Gross profit: 15811000
Operating income: -11164000
Net income: 5742000
Capital expenditures: 0
Operating cash flow: -5760000
Depreciation & amortization: 23271000
Net tangible assets: 209045000
Owner earnings: 29013000
Return on net tangible assets (%): 13.878829917003516
Buffett classification: The Gruesome
Stock price: 2.68
P/E ratio: 16.327558967444336
Shares outstanding: 68679318
Book value: 226927000
P/B ratio: 0.811100363729305
Market cap (USD): 184060572.24
Debt to equity: 5.220524662116011
Current ratio: 1.5151021423831643
Quick ratio: 1.4876765570196226
Effective tax rate (%): -15.901840490797545
Interest coverage ratio: -0.44322693346037795
COGS to revenue (%): 88.98617960935105
SG&A to revenue (%): 2.654713143302962
Free cash flow (dilution-adjusted): -5835000
Buyback yield (%): 10.399837274786035
Retained earnings: -515837000
Inventory turnover: 27.596673147548067
Receivables turnover: 2.218965916995131
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6065637543927517
FCF margin (%): -4.064615899021985
Revenue growth (%): -19.835601445188384
Rule of 40 score: -23.90021734421037
Financial ratios for BHR — quarterly report dated 2025-12-31
Total revenue: 165562000
Gross profit: 30595000
Operating income: 589000
Net income: -33591000
Capital expenditures: 0
Operating cash flow: 8343000
Depreciation & amortization: 22766000
Net tangible assets: 135937000
Owner earnings: -10825000
Return on net tangible assets (%): -7.96324768091101
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.87
Shares outstanding: 68679318
Book value: 159783000
P/B ratio: 1.233608347946903
Market cap (USD): 197109642.66
Debt to equity: 7.031461419550265
Current ratio: 1.3565117233950654
Quick ratio: 1.3312305698791134
Interest coverage ratio: 0.025428485083970123
COGS to revenue (%): 81.52051799325932
SG&A to revenue (%): 4.437612495620976
Free cash flow (dilution-adjusted): 8769000
Buyback yield (%): 8.95136319151805
Retained earnings: -568503000
Inventory turnover: 28.468044716304576
Receivables turnover: 2.8143879511108842
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.03518096094793875
FCF margin (%): 5.2965052367089065
Revenue growth (%): 15.32920950709131
Rule of 40 score: 20.625714743800216
Financial ratios for BHR — annual report dated 2025-12-31
Total revenue: 704015000
Gross profit: 148391000
Operating income: 44059000
Net income: -22318000
Capital expenditures: 5509000
Operating cash flow: 40778000
Depreciation & amortization: 93006000
Net tangible assets: 135937000
Owner earnings: 65179000
Capex to operating income (%): 12.503688236228694
Buffett classification: The Great
Stock price: 2.87
Shares outstanding: 68679318
Book value: 159783000
P/B ratio: 1.233608347946903
Market cap (USD): 197109642.66
Debt to equity: 7.031461419550265
Current ratio: 1.3565117233950654
Quick ratio: 1.3312305698791134
Interest coverage ratio: 0.44712245912785803
COGS to revenue (%): 78.92218205578007
SG&A to revenue (%): 1.6695666995731624
Free cash flow (dilution-adjusted): 35715000
Buyback yield (%): 39.40700158134009
Retained earnings: -568503000
Inventory turnover: 117.19552836954229
Receivables turnover: 11.967548914614039
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6316433928781553
FCF margin (%): 5.0730453186366775
Revenue growth (%): -3.3482792516240987
Rule of 40 score: 1.7247660670125788
Financial ratios for CALY — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.44
Shares outstanding: 179757563
Market cap (USD): 4932547528.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CALY — annual report dated 2022-12-31
Total revenue: 3995700000
Gross profit: 2411100000
Operating income: 287200000
Net income: 157900000
Capital expenditures: 0
Operating cash flow: -35100000
Depreciation & amortization: 192800000
Net tangible assets: 286800000
Owner earnings: 350700000
Return on net tangible assets (%): 122.28033472803348
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 19.75
P/E ratio: 22.48392570772641
Shares outstanding: 179757563
Book value: 3774300000
P/B ratio: 0.9406278963648889
Market cap (USD): 3550211869.25
Debt to equity: 0.9452083830114193
Current ratio: 1.2913620132630506
Quick ratio: 0.4758544465227002
Effective tax rate (%): -11.27554615926709
Interest coverage ratio: 2.011204481792717
COGS to revenue (%): 39.657631954350926
R&D to revenue (%): 1.9120554596190904
SG&A to revenue (%): 24.2911129464174
Free cash flow (dilution-adjusted): -617600000
Buyback yield (%): 1.008390521987718
Retained earnings: 852500000
Inventory turnover: 1.652001668056714
Receivables turnover: 16.196595054722334
Capitalized R&D asset: 76400000
ROCI (R&D-adjusted, %): 4.514102119100383
FCF margin (%): -15.456615862051706
Rule of 40 score: -15.456615862051706
Financial ratios for CALY — annual report dated 2023-12-31
Total revenue: 2132700000
Gross profit: 927100000
Operating income: 194100000
Net income: 95000000
Capital expenditures: 300000
Operating cash flow: 364700000
Depreciation & amortization: 45700000
Net tangible assets: 413200000
Owner earnings: 140400000
Return on net tangible assets (%): 33.978702807357216
Capex to operating income (%): 0.1545595054095827
Buffett classification: The Great
Stock price: 14.34
P/E ratio: 27.133931088631577
Shares outstanding: 179757563
Book value: 3878200000
P/B ratio: 0.664670066891857
Market cap (USD): 2577723453.42
Debt to equity: 1.0501521324325718
Current ratio: 1.7181300126635712
Quick ratio: 0.8798016040523428
Effective tax rate (%): 23.166023166023166
Interest coverage ratio: 2.7454031117397455
COGS to revenue (%): 56.52928213063253
R&D to revenue (%): 2.8977352651568435
SG&A to revenue (%): 48.60505462559197
Free cash flow (dilution-adjusted): 281400000
Buyback yield (%): 2.1724595757431575
Retained earnings: 947500000
Inventory turnover: 1.5176233635448138
Receivables turnover: 6.339774078478002
Capitalized R&D asset: 112988000
ROCI (R&D-adjusted, %): 2.532387608253033
Rosenberg metric: -19.42408376963351
FCF margin (%): 13.194542129694753
Revenue growth (%): -46.625122006156616
Rule of 40 score: -33.43057987646186
Financial ratios for CALY — quarterly report dated 2024-09-30
Capital expenditures: 100000
Buffett classification: The Gruesome
Stock price: 10.98
Shares outstanding: 179757563
Market cap (USD): 1973738041.74
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CALY — annual report dated 2024-12-31
Total revenue: 2077700000
Gross profit: 887000000
Operating income: 152900000
Net income: -1447700000
Capital expenditures: 600000
Operating cash flow: 382000000
Depreciation & amortization: 44500000
Net tangible assets: 1566500000
Owner earnings: -1403800000
Return on net tangible assets (%): -89.61378870092564
Capex to operating income (%): 0.3924133420536298
Buffett classification: The Great
Stock price: 7.86
Shares outstanding: 179757563
Book value: 2407700000
P/B ratio: 0.5868232940897953
Market cap (USD): 1412894445.18
Debt to equity: 0.6798604477301989
Current ratio: 1.9381281026758688
Quick ratio: 1.1775033297009323
Effective tax rate (%): 16.233183856502244
Interest coverage ratio: 2.426984126984127
COGS to revenue (%): 57.308562352601434
R&D to revenue (%): 3.0851422245752516
SG&A to revenue (%): 32.247196419117294
Free cash flow (dilution-adjusted): 303800000
Buyback yield (%): 2.222388240474659
Retained earnings: -500200000
Inventory turnover: 1.8954154727793697
Receivables turnover: 12.865015479876162
Capitalized R&D asset: 130718000
ROCI (R&D-adjusted, %): 2.1548542522281156
Rosenberg metric: -0.6488673139158576
FCF margin (%): 14.621937719593781
Revenue growth (%): -2.5788906081492944
Rule of 40 score: 12.043047111444487
Financial ratios for CALY — quarterly report dated 2024-12-31
Capital expenditures: 300000
Buffett classification: The Gruesome
Stock price: 7.86
Shares outstanding: 179757563
Market cap (USD): 1412894445.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CALY — quarterly report dated 2025-03-31
Total revenue: 629600000
Gross profit: 283600000
Operating income: 103100000
Net income: 2100000
Capital expenditures: 7800000
Operating cash flow: -85200000
Depreciation & amortization: 11700000
Net tangible assets: 643800000
Owner earnings: 6000000
Return on net tangible assets (%): 0.9319664492078285
Capex to operating income (%): 7.565470417070805
Buffett classification: The Great
Stock price: 6.59
P/E ratio: 141.0240881154762
Shares outstanding: 179757563
Book value: 2426600000
P/B ratio: 0.48817371638094453
Market cap (USD): 1184602340.17
Debt to equity: 1.1954586664468805
Current ratio: 2.1158733577428386
Quick ratio: 1.4116950247684688
Effective tax rate (%): 30.022075055187635
Interest coverage ratio: 6.919463087248322
COGS to revenue (%): 54.95552731893265
R&D to revenue (%): 2.5254129606099114
SG&A to revenue (%): 26.143583227445998
Free cash flow (dilution-adjusted): -98900000
Buyback yield (%): 0.278574496106974
Retained earnings: -498100000
Inventory turnover: 0.5291328949380639
Receivables turnover: 1.3507830937567045
Capitalized R&D asset: 15900000
ROCI (R&D-adjusted, %): 1.676694390373385
FCF margin (%): -15.70838627700127
Rule of 40 score: -15.70838627700127
Financial ratios for CALY — quarterly report dated 2025-06-30
Total revenue: 1110500000
Gross profit: 705600000
Operating income: 107600000
Net income: 20300000
Capital expenditures: 137300000
Operating cash flow: 126900000
Depreciation & amortization: 125200000
Net tangible assets: 704700000
Owner earnings: 8200000
Return on net tangible assets (%): 1.1636157230026962
Capex to operating income (%): 127.60223048327137
Buffett classification: The Gruesome
Stock price: 8.05
P/E ratio: 64.600374203125
Shares outstanding: 179757563
Book value: 2488100000
P/B ratio: 0.58158771036132
Market cap (USD): 1447048382.15
Debt to equity: 1.1665125999758852
Current ratio: 1.8522201437432313
Quick ratio: 1.2527321059367924
Effective tax rate (%): 40.469208211143695
Interest coverage ratio: 1.8330494037478706
COGS to revenue (%): 36.461053579468704
R&D to revenue (%): 1.7829806393516434
SG&A to revenue (%): 21.773975686627644
Free cash flow (dilution-adjusted): -18500000
Buyback yield (%): 0
Retained earnings: -477800000
Inventory turnover: 0.6649696173427492
Receivables turnover: 2.437980241492865
Capitalized R&D asset: 30453000
ROCI (R&D-adjusted, %): 1.7441720868135606
Rosenberg metric: 26.540880503144653
FCF margin (%): -1.6659162539396668
Revenue growth (%): 76.38182973316391
Rule of 40 score: 74.71591347922424
Financial ratios for CALY — quarterly report dated 2025-09-30
Total revenue: 934000000
Gross profit: 604300000
Operating income: 30700000
Net income: -14700000
Capital expenditures: 0
Operating cash flow: 228400000
Depreciation & amortization: 65500000
Net tangible assets: 694300000
Owner earnings: 50800000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.5
P/E ratio: 221.77881149350648
Shares outstanding: 179757563
Book value: 2475700000
P/B ratio: 0.6897834343821949
Market cap (USD): 1707696848.5
Debt to equity: 1.2853738336632063
Current ratio: 1.870832081706218
Quick ratio: 1.3013918093521577
Interest coverage ratio: 0.518581081081081
COGS to revenue (%): 35.29978586723769
R&D to revenue (%): 2.15203426124197
SG&A to revenue (%): 22.548179871520343
Free cash flow (dilution-adjusted): 158100000
Buyback yield (%): 0.005855840284991894
Retained earnings: -492500000
Inventory turnover: 0.5797432741339898
Receivables turnover: 3.0713581058862216
Capitalized R&D asset: 38613000
ROCI (R&D-adjusted, %): 0.4871397378492296
Rosenberg metric: -5.116161616161616
FCF margin (%): 16.927194860813703
Revenue growth (%): -15.893741557856822
Rule of 40 score: 1.0334533029568806
Financial ratios for CALY — quarterly report dated 2025-12-31
Total revenue: -1076700000
Gross profit: -1109800000
Operating income: -77300000
Net income: -417000000
Capital expenditures: 0
Operating cash flow: 63900000
Depreciation & amortization: -150500000
Net tangible assets: 1226700000
Owner earnings: -567500000
Return on net tangible assets (%): -46.2623298279938
Buffett classification: The Gruesome
Stock price: 11.67
Shares outstanding: 179757563
Book value: 2068900000
P/B ratio: 1.0139546426651844
Market cap (USD): 2097770760.21
Debt to equity: 0.8087872782638117
Current ratio: 1.3590383514596451
Quick ratio: 1.2158672009158558
Effective tax rate (%): 51.557632398753896
Free cash flow (dilution-adjusted): 236900000
Buyback yield (%): 0.014300895297538046
Retained earnings: -909500000
Inventory turnover: 0.052934591396129854
Receivables turnover: -6.650401482396541
Capitalized R&D asset: 24301000
ROCI (R&D-adjusted, %): -2.9812866494653676
Rosenberg metric: -85.27860696517413
Revenue growth (%): -215.27837259100644
Rule of 40 score: -215.27837259100644
Financial ratios for CALY — annual report dated 2025-12-31
Total revenue: 2060100000
Gross profit: 867600000
Operating income: 128100000
Net income: -409300000
Capital expenditures: 32600000
Operating cash flow: 334000000
Depreciation & amortization: 46400000
Net tangible assets: 1226700000
Owner earnings: -395500000
Return on net tangible assets (%): -32.2409717127252
Capex to operating income (%): 25.448868071818893
Buffett classification: The Good
Stock price: 11.67
Shares outstanding: 179757563
Book value: 2068900000
P/B ratio: 1.0139546426651844
Market cap (USD): 2097770760.21
Debt to equity: 0.8087872782638117
Current ratio: 1.3590383514596451
Quick ratio: 1.2158672009158558
Effective tax rate (%): 55.70776255707762
Interest coverage ratio: 2.113861386138614
COGS to revenue (%): 57.88553953691569
R&D to revenue (%): 3.1794573078976747
SG&A to revenue (%): 32.7168584049318
Free cash flow (dilution-adjusted): 277600000
Buyback yield (%): 0.1763777086696359
Retained earnings: -909500000
Inventory turnover: 1.9070845993922918
Receivables turnover: 12.724521309450278
Capitalized R&D asset: 128841000
ROCI (R&D-adjusted, %): 4.259451108359714
Rosenberg metric: -0.30265210608424337
FCF margin (%): 13.475074025532741
Revenue growth (%): -0.8470905328006931
Rule of 40 score: 12.627983492732048
Financial ratios for CCE.AX — annual report dated 2021-06-30
Capital expenditures: 118835.33834586466
Buffett classification: The Gruesome
Stock price: 0.07518796992481203
Shares outstanding: 413414223
Market cap (USD): 31083776.165413532
Buyback yield (%): 0.07605930868034019
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCE.AX — annual report dated 2022-06-30
Total revenue: 222026.20689655174
Gross profit: 222026.20689655174
Operating income: -1600546.206896552
Net income: -1327365.5172413792
Capital expenditures: 138954.4827586207
Depreciation & amortization: 195536.55172413794
Net tangible assets: 4316084.137931035
Owner earnings: -1270783.448275862
Return on net tangible assets (%): -29.442972093797664
Buffett classification: The Gruesome
Stock price: 0.034482758620689655
Shares outstanding: 413414223
Book value: 14299086.206896551
P/B ratio: 0.9969632084037201
Market cap (USD): 14255662.862068966
Debt to equity: 0.008084191538644259
Current ratio: 6.7212684553103665
Quick ratio: 6.7212684553103665
Interest coverage ratio: -395.02842553191493
COGS to revenue (%): 0
SG&A to revenue (%): 655.3563108424603
Free cash flow (dilution-adjusted): -35077.24137931035
Buyback yield (%): 0
Retained earnings: -130408613.79310346
Receivables turnover: 2.334558850189629
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.109758502180338
FCF margin (%): -15.798694158502569
Rule of 40 score: -15.798694158502569
Financial ratios for CCE.AX — annual report dated 2023-06-30
Total revenue: 254130.46357615895
Gross profit: 254130.46357615895
Operating income: -1539519.8675496688
Net income: -417480.7947019868
Capital expenditures: 412192.05298013246
Depreciation & amortization: 207631.12582781457
Net tangible assets: 4559698.013245033
Owner earnings: -622041.7218543047
Return on net tangible assets (%): -13.6421692850578
Buffett classification: The Gruesome
Stock price: 0.052980132450331126
Shares outstanding: 413414223
Book value: 14055865.562913908
P/B ratio: 1.5582633594035382
Market cap (USD): 21902740.29139073
Debt to equity: 0.005225929812620472
Current ratio: 4.329414824967735
Quick ratio: 4.329414824967735
Interest coverage ratio: -213.13605941138718
COGS to revenue (%): 0
R&D to revenue (%): 90.21986412569025
SG&A to revenue (%): 483.0998835139692
Free cash flow (dilution-adjusted): -1878721.1920529802
Buyback yield (%): 0
Retained earnings: -124997574.83443709
Receivables turnover: 0.12278908168894384
Capitalized R&D asset: 229276.15894039735
ROCI (R&D-adjusted, %): -9.67813866744269
FCF margin (%): -739.2742946340853
Revenue growth (%): 14.459669931921812
Rule of 40 score: -724.8146247021635
Financial ratios for CCE.AX — annual report dated 2024-06-30
Total revenue: 231280.66666666666
Gross profit: 129742
Operating income: -1605170.6666666667
Net income: -1546816.6666666667
Capital expenditures: 13778.666666666666
Depreciation & amortization: 212594
Net tangible assets: 3755232
Owner earnings: -1348001.3333333335
Return on net tangible assets (%): -35.89661925903202
Buffett classification: The Gruesome
Stock price: 0.02666666666666667
Shares outstanding: 413414223
Book value: 14065489.333333332
P/B ratio: 0.7837892460572768
Market cap (USD): 11024379.280000001
Debt to equity: 0.0016217471092604245
Current ratio: 3.1273770715557654
Quick ratio: 3.1273770715557654
Interest coverage ratio: -186.51762336354483
COGS to revenue (%): 43.90279054885695
R&D to revenue (%): 29.244121860596508
SG&A to revenue (%): 564.0615586833891
Free cash flow (dilution-adjusted): -3050802
Buyback yield (%): 0.006694254445135527
Retained earnings: -127360308.66666667
Receivables turnover: 2.729125694236851
Capitalized R&D asset: 221251.02649006623
ROCI (R&D-adjusted, %): -11.43380929105545
Rosenberg metric: -0.5425268119939806
FCF margin (%): -1319.0908016522494
Revenue growth (%): -8.991364745472382
Rule of 40 score: -1328.0821663977217
Financial ratios for CFT.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 93.65934065934066
Shares outstanding: 7680770
Market cap (USD): 719375853.956044
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CFT.SW — annual report dated 2022-12-31
Total revenue: 1029780434.7826086
Gross profit: 290636956.5217391
Operating income: 102355434.78260869
Net income: 105889130.43478261
Capital expenditures: 3875000
Operating cash flow: 147530434.7826087
Depreciation & amortization: 28879347.826086957
Net tangible assets: 405455434.7826087
Owner earnings: 130893478.26086956
Return on net tangible assets (%): 32.28307405252816
Capex to operating income (%): 3.7858273068059938
Buffett classification: The Great
Stock price: 97.56521739130434
P/E ratio: 7.076986955182821
Shares outstanding: 7680770
Book value: 480995652.1739131
P/B ratio: 1.5579683338003596
Market cap (USD): 749375994.7826086
Debt to equity: 0.6353329597121911
Current ratio: 2.063043933200329
Quick ratio: 2.063043933200329
Effective tax rate (%): 18.864985966402653
Interest coverage ratio: 9.241118743866537
COGS to revenue (%): 71.77680341313788
SG&A to revenue (%): 8.175761401227362
Free cash flow (dilution-adjusted): 140015217.39130434
Buyback yield (%): 2.6352360129557253
Retained earnings: 666497826.0869565
Receivables turnover: 3.2162066741351802
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.098944205650376
FCF margin (%): 13.596608816991381
Rule of 40 score: 13.596608816991381
Financial ratios for CFT.SW — annual report dated 2023-12-31
Total revenue: 1169505952.3809524
Gross profit: 324045238.0952381
Operating income: 125601190.47619048
Net income: 120303571.42857143
Capital expenditures: 4936904.761904762
Operating cash flow: 143616666.6666667
Depreciation & amortization: 27539285.714285716
Net tangible assets: 422476190.4761905
Owner earnings: 142905952.38095236
Return on net tangible assets (%): 33.825800270513966
Capex to operating income (%): 3.930619401924079
Buffett classification: The Great
Stock price: 127.67857142857143
P/E ratio: 8.151626168917915
Shares outstanding: 7680770
Book value: 507121428.57142866
P/B ratio: 1.9337966921137508
Market cap (USD): 980669741.0714285
Debt to equity: 0.6015512392542407
Current ratio: 2.344914840510751
Quick ratio: 2.344914840510751
Effective tax rate (%): 20.55424528301887
Interest coverage ratio: 13.737630208333332
COGS to revenue (%): 72.29212579589468
SG&A to revenue (%): 8.051120487385292
Free cash flow (dilution-adjusted): 130090476.19047618
Buyback yield (%): 1.463771268100782
Retained earnings: 786838095.2380953
Receivables turnover: 4.527203266419657
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.238855941138915
FCF margin (%): 11.12354117784779
Revenue growth (%): 13.568476626557818
Rule of 40 score: 24.69201780440561
Financial ratios for CFT.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 483113333.3333333
Buffett classification: The Gruesome
Stock price: 193.9777777777778
Shares outstanding: 7680770
Book value: 562162222.2222223
P/B ratio: 2.6503002822435593
Market cap (USD): 1489898696.2222223
Debt to equity: 0.6923723085072319
Current ratio: 1.772436069889985
Quick ratio: 1.772436069889985
Buyback yield (%): 0
Retained earnings: 815923333.3333333
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CFT.SW — annual report dated 2024-12-31
Total revenue: 1168442222.222222
Gross profit: 336611111.1111111
Operating income: 139255555.55555555
Net income: 137017777.77777776
Capital expenditures: 4617777.777777778
Operating cash flow: 119771111.1111111
Depreciation & amortization: 25935555.555555556
Net tangible assets: 483113333.3333333
Owner earnings: 158335555.55555552
Return on net tangible assets (%): 32.77399827967672
Capex to operating income (%): 3.3160456395116897
Buffett classification: The Great
Stock price: 193.9777777777778
P/E ratio: 10.873761933569044
Shares outstanding: 7680770
Book value: 562162222.2222223
P/B ratio: 2.6503002822435593
Market cap (USD): 1489898696.2222223
Debt to equity: 0.6923723085072319
Current ratio: 1.772436069889985
Quick ratio: 1.772436069889985
Effective tax rate (%): 19.662796909405987
Interest coverage ratio: 16.38514838540986
COGS to revenue (%): 71.19146289741897
SG&A to revenue (%): 7.802316094172869
Free cash flow (dilution-adjusted): 109403333.33333334
Buyback yield (%): 1.6464952397979837
Retained earnings: 815923333.3333333
Receivables turnover: 2.8932897890007454
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.91920146444983
FCF margin (%): 9.36317870517061
Revenue growth (%): -0.09095551472522743
Rule of 40 score: 9.272223190445382
Financial ratios for CFT.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 503760000
Buffett classification: The Gruesome
Stock price: 265.4375
Shares outstanding: 7680770
Market cap (USD): 2038764386.875
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMC.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 139.7840909090909
Shares outstanding: 2658200000
Market cap (USD): 371574070454.5455
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMC.DE — annual report dated 2022-12-31
Total revenue: 127727000000
Net income: 37676000000
Capital expenditures: 0
Operating cash flow: 107119000000
Depreciation & amortization: 7051000000
Net tangible assets: 231473000000
Owner earnings: 44727000000
Return on net tangible assets (%): 19.32277198636558
Buffett classification: The Gruesome
Stock price: 119.88297872340426
P/E ratio: 8.458247532714545
Shares outstanding: 2658200000
Book value: 292332000000
P/B ratio: 1.0901062286802445
Market cap (USD): 318672934042.5532
Debt to equity: 1.1626917340557996
Effective tax rate (%): 18.390157258588573
COGS to revenue (%): 0
SG&A to revenue (%): 35.65964909533615
Free cash flow (dilution-adjusted): 107119000000
Buyback yield (%): 3.3250392073099904
Retained earnings: 296456000000
Receivables turnover: 1.02027334669979
Capitalized R&D asset: 0
FCF margin (%): 83.86558832509962
Rule of 40 score: 83.86558832509962
Financial ratios for CMC.DE — annual report dated 2023-12-31
Total revenue: 154952000000
Net income: 49552000000
Capital expenditures: 0
Operating cash flow: 12974000000
Depreciation & amortization: 7512000000
Net tangible assets: 263497000000
Owner earnings: 57064000000
Return on net tangible assets (%): 21.656413545505263
Buffett classification: The Gruesome
Stock price: 160.37777777777777
P/E ratio: 8.603410737990169
Shares outstanding: 2658200000
Book value: 327878000000
P/B ratio: 1.3002281607454262
Market cap (USD): 426316208888.88885
Debt to equity: 1.3314007039203606
Effective tax rate (%): 19.57410893981692
COGS to revenue (%): 0
SG&A to revenue (%): 32.94955857297744
Free cash flow (dilution-adjusted): 12974000000
Buyback yield (%): 2.304392794635786
Retained earnings: 332901000000
Receivables turnover: 1.4432532622970669
Capitalized R&D asset: 0
FCF margin (%): 8.372915483504569
Revenue growth (%): 21.314992131655796
Rule of 40 score: 29.687907615160363
Financial ratios for CMC.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 199.46666666666667
Shares outstanding: 2658200000
Market cap (USD): 530222293333.3333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMC.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 229.19791666666669
Shares outstanding: 2658200000
Market cap (USD): 609253902083.3334
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMC.DE — annual report dated 2024-12-31
Total revenue: 169439000000
Net income: 58471000000
Capital expenditures: 0
Operating cash flow: -42012000000
Depreciation & amortization: 7938000000
Net tangible assets: 280198000000
Owner earnings: 66409000000
Return on net tangible assets (%): 23.70074019086503
Buffett classification: The Gruesome
Stock price: 229.19791666666669
P/E ratio: 10.419761968896262
Shares outstanding: 2658200000
Book value: 344758000000
P/B ratio: 1.767192935576066
Market cap (USD): 609253902083.3334
Debt to equity: 1.3177678255471954
Effective tax rate (%): 22.122774070670342
COGS to revenue (%): 0
SG&A to revenue (%): 33.24559280921158
Free cash flow (dilution-adjusted): -42012000000
Buyback yield (%): 4.7073970149274755
Retained earnings: 376166000000
Receivables turnover: 1.6739179830670894
Capitalized R&D asset: 0
FCF margin (%): -24.794763897331784
Revenue growth (%): 9.349346894522174
Rule of 40 score: -15.44541700280961
Financial ratios for CMC.DE — quarterly report dated 2025-03-31
Total revenue: 45327000000
Net income: 14643000000
Capital expenditures: 0
Operating cash flow: -251839000000
Depreciation & amortization: 2030000000
Net tangible assets: 286895000000
Owner earnings: 16673000000
Return on net tangible assets (%): 5.81153383642099
Buffett classification: The Gruesome
Stock price: 234.9891304347826
P/E ratio: 10.664619724812864
Shares outstanding: 2658200000
Book value: 351420000000
P/B ratio: 1.7774973152402798
Market cap (USD): 624648106521.7391
Debt to equity: 1.3437026919355757
Effective tax rate (%): 20.453063885267277
COGS to revenue (%): 0
SG&A to revenue (%): 34.70558386833454
Free cash flow (dilution-adjusted): -251839000000
Buyback yield (%): 1.6854289463268552
Retained earnings: 386616000000
Receivables turnover: 0.3846323560609275
Capitalized R&D asset: 0
FCF margin (%): -555.6048271449688
Rule of 40 score: -555.6048271449688
Financial ratios for CMC.DE — quarterly report dated 2025-06-30
Total revenue: 44882000000
Net income: 14987000000
Capital expenditures: 0
Operating cash flow: 29547000000
Depreciation & amortization: 2210000000
Net tangible assets: 292459000000
Owner earnings: 17197000000
Return on net tangible assets (%): 5.880140464133434
Buffett classification: The Gruesome
Stock price: 284.6235294117647
P/E ratio: 25.534467292688255
Shares outstanding: 2658200000
Book value: 356924000000
P/B ratio: 2.1197405214621403
Market cap (USD): 756586265882.3529
Debt to equity: 1.3590988557788213
Effective tax rate (%): 18.03215926493109
COGS to revenue (%): 0
SG&A to revenue (%): 33.39646183325164
Free cash flow (dilution-adjusted): 29547000000
Buyback yield (%): 0.992087794674185
Retained earnings: 397424000000
Receivables turnover: 0.36060515976635626
Capitalized R&D asset: 0
FCF margin (%): 65.83262777951072
Revenue growth (%): -0.9817548039799678
Rule of 40 score: 64.85087297553075
Financial ratios for CMC.DE — quarterly report dated 2025-09-30
Total revenue: 46430000000
Net income: 14393000000
Capital expenditures: 0
Operating cash flow: -45214000000
Depreciation & amortization: 2269000000
Net tangible assets: 295770000000
Owner earnings: 16662000000
Return on net tangible assets (%): 5.6334313824931534
Buffett classification: The Gruesome
Stock price: 305.8
P/E ratio: 18.464837925629784
Shares outstanding: 2658200000
Book value: 360212000000
P/B ratio: 2.25666429769136
Market cap (USD): 812877560000
Debt to equity: 1.3785159850310373
Effective tax rate (%): 23.208664568105426
COGS to revenue (%): 0
SG&A to revenue (%): 32.40577213008831
Free cash flow (dilution-adjusted): -45214000000
Buyback yield (%): 1.020202845801279
Retained earnings: 407401000000
Receivables turnover: 0.32725760523273845
Capitalized R&D asset: 0
FCF margin (%): -97.38100366142581
Revenue growth (%): 3.4490441602424133
Rule of 40 score: -93.9319595011834
Financial ratios for CMC.DE — quarterly report dated 2025-12-31
Total revenue: 45796000000
Net income: 13025000000
Capital expenditures: 0
Operating cash flow: 119724000000
Depreciation & amortization: 2312000000
Net tangible assets: 297980000000
Owner earnings: 15337000000
Return on net tangible assets (%): 5.14698973085442
Buffett classification: The Gruesome
Stock price: 320.0470588235294
P/E ratio: 14.912864460887425
Shares outstanding: 2658200000
Book value: 362438000000
P/B ratio: 2.3472955147217065
Market cap (USD): 850749091764.7059
Debt to equity: 1.379496631147948
Effective tax rate (%): 24.096736596736594
COGS to revenue (%): 0
SG&A to revenue (%): 31.84994322648266
Free cash flow (dilution-adjusted): 119724000000
Buyback yield (%): 0.9713792327251286
Retained earnings: 416055000000
Receivables turnover: 0.4103621000188174
Capitalized R&D asset: 0
FCF margin (%): 261.42894575945496
Revenue growth (%): -1.365496446263192
Rule of 40 score: 260.06344931319177
Financial ratios for CMC.DE — annual report dated 2025-12-31
Total revenue: 181847000000
Net income: 57048000000
Capital expenditures: 0
Operating cash flow: -147782000000
Depreciation & amortization: 8821000000
Net tangible assets: 297980000000
Owner earnings: 65869000000
Return on net tangible assets (%): 22.105174843949257
Buffett classification: The Gruesome
Stock price: 320.0470588235294
P/E ratio: 14.912864460887425
Shares outstanding: 2658200000
Book value: 362438000000
P/B ratio: 2.3472955147217065
Market cap (USD): 850749091764.7059
Debt to equity: 1.379496631147948
Effective tax rate (%): 21.416075487292513
COGS to revenue (%): 0
SG&A to revenue (%): 33.004668760001536
Free cash flow (dilution-adjusted): -147782000000
Buyback yield (%): 4.065946156727362
Retained earnings: 416055000000
Receivables turnover: 1.6294680059857167
Capitalized R&D asset: 0
FCF margin (%): -81.2672191457654
Revenue growth (%): 7.322989394413329
Rule of 40 score: -73.94422975135207
Financial ratios for COS.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.06666666666666667
Shares outstanding: 34417470
Market cap (USD): 2294498
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COS.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -148142.65734265736
Net income: -208590.2097902098
Capital expenditures: 0
Operating cash flow: -99787.41258741259
Net tangible assets: 191671.32867132867
Owner earnings: -208590.2097902098
Return on net tangible assets (%): -108.82702761866541
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 34417470
Book value: 191671.3286713287
P/B ratio: 7.534197526359954
Market cap (USD): 1444089.6503496503
Debt to equity: 0
Current ratio: 1.9594099815881774
Quick ratio: 1.9594099815881774
Free cash flow (dilution-adjusted): -99787.41258741259
Buyback yield (%): 0
Retained earnings: -6843432.167832168
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -77.28994126017001
Rule of 40 score: 0
Financial ratios for COS.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -514683.2167832168
Net income: -1512073.4265734267
Capital expenditures: 0
Operating cash flow: -417203.49650349654
Net tangible assets: 191671.32867132867
Owner earnings: -1512073.4265734267
Return on net tangible assets (%): -788.8886861979643
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 34417470
Book value: 191671.3286713287
P/B ratio: 7.534197526359954
Market cap (USD): 1444089.6503496503
Debt to equity: 0
Current ratio: 1.9594099815881774
Quick ratio: 1.9594099815881774
Free cash flow (dilution-adjusted): -417203.49650349654
Buyback yield (%): 0
Retained earnings: -6843432.167832168
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -268.5238425334744
Rule of 40 score: 0
Financial ratios for COS.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -120355.94405594406
Net income: -120355.94405594406
Capital expenditures: 0
Operating cash flow: -30171.328671328672
Net tangible assets: 130104.89510489511
Owner earnings: -120355.94405594406
Return on net tangible assets (%): -92.50685299650631
Buffett classification: The Gruesome
Stock price: 0.02097902097902098
Shares outstanding: 34417470
Book value: 130104.89510489511
P/B ratio: 5.549712980381618
Market cap (USD): 722044.8251748251
Debt to equity: 0
Current ratio: 1.5659195089382127
Quick ratio: 1.5659195089382127
Free cash flow (dilution-adjusted): -53991.608391608395
Buyback yield (%): 0
Retained earnings: -6928823.076923077
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -92.50685299650631
Rule of 40 score: 0
Financial ratios for COS.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -106462.77372262772
Net income: -106462.77372262772
Capital expenditures: 0
Operating cash flow: -96619.70802919708
Net tangible assets: 29340.145985401457
Owner earnings: -106462.77372262772
Return on net tangible assets (%): -362.85700069658674
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
Shares outstanding: 34417470
Book value: 29340.14598540144
P/B ratio: 34.24964673101803
Market cap (USD): 1004889.6350364963
Debt to equity: 0
Current ratio: 1.1301401574140324
Quick ratio: 1.1301401574140324
Free cash flow (dilution-adjusted): -96619.70802919708
Buyback yield (%): 0
Retained earnings: -7338737.956204379
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -362.85700069658697
Rule of 40 score: 0
Financial ratios for COS.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -133284.89208633095
Net income: -133284.89208633095
Capital expenditures: 0
Operating cash flow: -18383.453237410075
Net tangible assets: -104360.43165467627
Owner earnings: -133284.89208633095
Buffett classification: The Gruesome
Stock price: 0.05035971223021583
Shares outstanding: 34417470
Book value: -104360.43165467624
Market cap (USD): 1733253.8848920865
Debt to equity: 0
Current ratio: 0.6746336682075817
Quick ratio: 0.6746336682075817
Free cash flow (dilution-adjusted): -18383.453237410075
Buyback yield (%): 0
Retained earnings: -7366429.496402878
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSX — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 46013636.36363637
Buffett classification: The Gruesome
Stock price: 2.64
Shares outstanding: 124402479
Market cap (USD): 328422544.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSX — annual report dated 2022-12-31
Total revenue: 308480851.0638298
Gross profit: 178373404.25531915
Operating income: 146870212.76595744
Net income: 126662765.95744681
Capital expenditures: 241060638.29787236
Operating cash flow: 168998936.17021278
Depreciation & amortization: 46091489.36170213
Net tangible assets: 518434042.55319154
Owner earnings: -68306382.9787234
Return on net tangible assets (%): -13.175520388732023
Capex to operating income (%): 164.13174173173596
Buffett classification: The Gruesome
Stock price: 3.12
P/E ratio: 3.0643238488128133
Shares outstanding: 124402479
Book value: 518434042.5531914
P/B ratio: 0.7486694596066716
Market cap (USD): 388135734.48
Debt to equity: 1.072195728544225
Current ratio: 1.0683834092135565
Quick ratio: 1.0338382725151443
Interest coverage ratio: 5.58532243709038
COGS to revenue (%): 42.17683086642849
SG&A to revenue (%): 10.127529554577684
Free cash flow (dilution-adjusted): -76712765.95744681
Buyback yield (%): 1.0412567054967672
Retained earnings: -611694680.8510638
Inventory turnover: 26.90891089108911
Receivables turnover: 45.72248502049826
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.131472618114582
FCF margin (%): -24.86791828176514
Rule of 40 score: -24.86791828176514
Financial ratios for DSX — annual report dated 2023-12-31
Total revenue: 291220000
Gross profit: 125784444.44444445
Operating income: 89321111.1111111
Net income: 55382222.222222224
Capital expenditures: 5357777.777777778
Operating cash flow: 78200000
Net tangible assets: 543356666.6666666
Owner earnings: 50024444.44444445
Return on net tangible assets (%): 9.206557591596273
Capex to operating income (%): 5.998333105275598
Buffett classification: The Great
Stock price: 2.66
P/E ratio: 5.97503279684616
Shares outstanding: 124402479
Book value: 543356666.6666667
P/B ratio: 0.6090117494463428
Market cap (USD): 330910594.14000005
Debt to equity: 1.0442148701180518
Current ratio: 2.1404021894895107
Quick ratio: 2.0810134611318625
Interest coverage ratio: 1.7324095424864772
COGS to revenue (%): 56.807758929865926
SG&A to revenue (%): 12.5785011713176
Free cash flow (dilution-adjusted): 42935555.55555555
Buyback yield (%): 0.02652613102517993
Retained earnings: -682076666.6666666
Inventory turnover: 29.448575949367086
Receivables turnover: 43.54510716065791
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.434642034041261
FCF margin (%): 14.743340277300856
Revenue growth (%): -5.595436800794557
Rule of 40 score: 9.147903476506299
Financial ratios for DSX — quarterly report dated 2024-09-30
Operating income: 18562222.22222222
Capital expenditures: 0
Operating cash flow: 21336666.666666668
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.49
Shares outstanding: 124402479
Market cap (USD): 309762172.71000004
Free cash flow (dilution-adjusted): 21336666.666666668
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSX — annual report dated 2024-12-31
Total revenue: 237717708.33333334
Gross profit: 90962500
Operating income: 55186458.333333336
Net income: 13277083.333333334
Capital expenditures: 11375000
Operating cash flow: 87010416.66666667
Net tangible assets: 526101041.6666667
Owner earnings: 1902083.333333334
Return on net tangible assets (%): 0.361543350552512
Capex to operating income (%): 20.611940580229902
Buffett classification: The Great
Stock price: 1.91
P/E ratio: 17.89615451862545
Shares outstanding: 124402479
Book value: 526101041.66666675
P/B ratio: 0.45164087517725715
Market cap (USD): 237608734.89
Debt to equity: 1.0189285565787622
Current ratio: 2.5768021950611124
Quick ratio: 2.524507358443502
Interest coverage ratio: 1.1842058205552326
COGS to revenue (%): 61.73507618016818
SG&A to revenue (%): 14.651043560946325
Free cash flow (dilution-adjusted): 61766666.66666667
Buyback yield (%): 0
Retained earnings: -662391666.6666667
Inventory turnover: 33.60004769854519
Receivables turnover: 33.76372244414854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.856724829901415
FCF margin (%): 25.983199610883005
Revenue growth (%): -18.371777922761712
Rule of 40 score: 7.611421688121293
Financial ratios for DSX — quarterly report dated 2024-12-31
Total revenue: 59451041.66666667
Gross profit: 23906250
Operating income: 15114583.333333334
Net income: 10142708.333333334
Capital expenditures: 0
Operating cash flow: 15775000
Net tangible assets: 526101041.6666667
Owner earnings: 10142708.333333334
Return on net tangible assets (%): 1.9279012071904755
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.91
P/E ratio: 5.856639249625141
Shares outstanding: 124402479
Book value: 526101041.66666675
P/B ratio: 0.45164087517725715
Market cap (USD): 237608734.89
Debt to equity: 1.0189285565787622
Current ratio: 2.5768021950611124
Quick ratio: 2.524507358443502
Interest coverage ratio: 1.6321709786276715
COGS to revenue (%): 59.78834124717467
SG&A to revenue (%): 14.581325670632348
Free cash flow (dilution-adjusted): -9468750
Buyback yield (%): 0
Retained earnings: -662391666.6666667
Inventory turnover: 8.138087288337706
Receivables turnover: 8.444000591803523
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.330170016079381
FCF margin (%): -15.926970721707287
Rule of 40 score: -15.926970721707287
Financial ratios for DSX — quarterly report dated 2025-03-31
Total revenue: 59714130.43478261
Gross profit: 22602173.913043477
Operating income: 13164130.434782607
Net income: 3257608.695652174
Capital expenditures: 0
Operating cash flow: 18708695.652173914
Net tangible assets: 526969565.21739125
Owner earnings: 3257608.695652174
Return on net tangible assets (%): 0.6181777678770327
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.53
P/E ratio: 14.607017804504505
Shares outstanding: 124402479
Book value: 526969565.21739125
P/B ratio: 0.36118934646914685
Market cap (USD): 190335792.87
Debt to equity: 1.286880275240712
Interest coverage ratio: 1.0932478786784618
COGS to revenue (%): 62.14937109780293
SG&A to revenue (%): 14.907985510675864
Free cash flow (dilution-adjusted): 18708695.652173914
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0589806120245147
FCF margin (%): 31.330433041483886
Revenue growth (%): 0.44253012351076726
Rule of 40 score: 31.772963164994653
Financial ratios for DSX — quarterly report dated 2025-06-30
Total revenue: 64338823.52941176
Gross profit: 23489411.76470588
Operating income: 12258823.529411765
Net income: 5343529.4117647065
Capital expenditures: 0
Operating cash flow: 10144705.88235294
Net tangible assets: 579814117.6470588
Owner earnings: 5343529.4117647065
Return on net tangible assets (%): 0.9215935330186957
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.44
P/E ratio: 9.55724697842915
Shares outstanding: 124402479
Book value: 579814117.6470587
P/B ratio: 0.30896034488943724
Market cap (USD): 179139569.76
Debt to equity: 0.9983199483810229
Current ratio: 2.2925433303057074
Quick ratio: 2.238630849435742
Interest coverage ratio: 1.0699250436389773
COGS to revenue (%): 63.49107665301346
SG&A to revenue (%): 16.352764774722058
Free cash flow (dilution-adjusted): 8288235.294117647
Buyback yield (%): 0
Retained earnings: -745361176.4705882
Inventory turnover: 8.013385645049619
Receivables turnover: 10.442619820507923
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9915839077922126
FCF margin (%): 12.8821679344646
Revenue growth (%): 7.744721493818048
Rule of 40 score: 20.62688942828265
Financial ratios for DSX — quarterly report dated 2025-09-30
Total revenue: 61012941.17647059
Gross profit: 19980000
Operating income: 10277647.05882353
Net income: 8421176.470588235
Capital expenditures: 0
Operating cash flow: 16897647.05882353
Net tangible assets: 587918823.5294118
Owner earnings: 8421176.470588235
Return on net tangible assets (%): 1.4323706153910802
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.67
P/E ratio: 7.647780773388783
Shares outstanding: 124402479
Book value: 587918823.5294117
P/B ratio: 0.35336875026864456
Market cap (USD): 207752139.92999998
Debt to equity: 1.3029269747123955
Interest coverage ratio: 0.8168302945301543
COGS to revenue (%): 67.25284896164749
SG&A to revenue (%): 15.414280480515222
Free cash flow (dilution-adjusted): 16897647.05882353
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7379269624625272
FCF margin (%): 27.695185206609974
Revenue growth (%): -5.169324166179043
Rule of 40 score: 22.525861040430932
Financial ratios for DSX — annual report dated 2025-12-31
Total revenue: 251224705.88235295
Gross profit: 87476470.5882353
Operating income: 45325882.35294118
Net income: 20972941.17647059
Capital expenditures: 23296470.588235296
Operating cash flow: 55890588.23529412
Net tangible assets: 591074117.6470588
Owner earnings: -2323529.4117647074
Return on net tangible assets (%): -0.39310288547469935
Capex to operating income (%): 51.39772107872401
Buffett classification: The Good
Stock price: 1.65
P/E ratio: 9.787091310792617
Shares outstanding: 124402479
Book value: 591074117.6470588
P/B ratio: 0.3472730140292946
Market cap (USD): 205264090.35
Debt to equity: 1.0405960833019845
Current ratio: 2.7335900870730074
Quick ratio: 2.6874079035498992
Interest coverage ratio: 0.9485437132235272
COGS to revenue (%): 65.17998885459936
SG&A to revenue (%): 15.96836204756932
Free cash flow (dilution-adjusted): 52157647.05882353
Buyback yield (%): 13.209955073686885
Retained earnings: -739374117.6470588
Inventory turnover: 33.64418660865361
Receivables turnover: 43.615400326797385
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.565294481275425
FCF margin (%): 20.761352620808182
Revenue growth (%): 5.681948410035897
Rule of 40 score: 26.44330103084408
Financial ratios for DSX — quarterly report dated 2025-12-31
Total revenue: 61240000
Gross profit: 19542352.94117647
Operating income: 8540000
Net income: 3681176.470588235
Capital expenditures: 0
Operating cash flow: 8598823.529411765
Net tangible assets: 591074117.6470588
Owner earnings: 3681176.470588235
Return on net tangible assets (%): 0.6227943942533334
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.65
P/E ratio: 9.91446755854956
Shares outstanding: 124402479
Book value: 591074117.6470588
P/B ratio: 0.3472730140292946
Market cap (USD): 205264090.35
Debt to equity: 1.0405960833019845
Current ratio: 2.7335900870730074
Quick ratio: 2.6874079035498992
Interest coverage ratio: 0.9037599601593624
COGS to revenue (%): 68.08890767280133
SG&A to revenue (%): 17.235947285511198
Free cash flow (dilution-adjusted): 4865882.352941177
Buyback yield (%): 0
Retained earnings: -739374117.6470588
Inventory turnover: 8.567319313512208
Receivables turnover: 10.631944444444445
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6717489718788983
FCF margin (%): 7.945594959080955
Revenue growth (%): 0.37214862806347015
Rule of 40 score: 8.317743587144426